Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-29 Sale | 2026-02-02 4:30 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 5,500 | $102.08 | $561,422 | 166,946 (Direct) | View |
| 2026-01-21 Sale | 2026-01-23 4:31 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 15,000 | $110.15 | $1,652,176 | 224,242 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:27 pm | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,160 | $97.24 | $501,753 | 100,888 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:26 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 7,417 | $97.25 | $721,320 | 75,617 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:26 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 6,952 | $97.26 | $676,158 | 77,134 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:26 pm | Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer | 7,417 | $97.25 | $721,320 | 90,130 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:25 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 7,417 | $97.25 | $721,320 | 116,733 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:25 pm | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,433 | $97.26 | $2,668,260 | 371,129 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 4:30 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 10,000 | $100.51 | $1,005,114 | 110,086 (Direct) | View |
| 2025-12-30 Sale | 2026-01-02 4:20 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $100.04 | $400,179 | 162,363 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:30 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 7,084 | $110.32 | $781,537 | 54,650 (Direct) | View |
| 2025-11-28 Sale | 2025-12-02 4:30 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $108.58 | $434,319 | 166,363 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:30 pm | Nuvalent Inc. | NUVL | Shair Matthew Director | 7,500 | $109.37 | $820,274 | 1,578,866 (Indirect Direct) | View |
| 2025-11-24 Sale | 2025-11-24 8:00 pm | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. Deerfield Mgmt HIF L.P. Deerfield Healthcare Innovations Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by Deputization Director 10% Owner | 742,574 | $95.44 | $70,874,975 | 8,949,225 (Indirect) | View |
| 2025-11-17 Sale | 2025-11-19 5:14 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 20,729 | $99.62 | $2,065,030 | 158,856 (Direct) | View |
| 2025-11-17 Sale | 2025-11-19 5:13 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 24,200 | $105.5 | $2,552,999 | 143,694 (Direct) | View |
| 2025-10-30 Sale | 2025-10-31 4:31 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $102.92 | $411,661 | 170,363 (Direct) | View |
| 2025-10-30 Sale | 2025-10-31 4:30 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 21,800 | $103.16 | $2,248,943 | 167,894 (Direct) | View |
| 2025-10-27 Sale | 2025-10-29 4:31 pm | Nuvalent Inc. | NUVL | Shair Matthew Director | 60,000 | $100.26 | $6,015,464 | 1,586,366 (Indirect Direct) | View |
| 2025-10-20 Sale | 2025-10-22 4:32 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 5,000 | $94.91 | $474,550 | 189,694 (Direct) | View |
| 2025-10-16 Sale | 2025-10-17 4:32 pm | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $90.63 | $2,447,021 | 471,462 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 4:32 pm | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 28,000 | $90.72 | $2,540,290 | 352,678 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 4:31 pm | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 14,205 | $90.04 | $1,279,018 | 113,746 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 4:31 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 1,683 | $85.57 | $144,014 | 90,713 (Direct) | View |
| 2025-10-13 Sale | 2025-10-15 4:30 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 40,000 | $87.36 | $3,494,303 | 179,034 (Direct) | View |
| 2025-10-13 Sale | 2025-10-15 4:30 pm | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 10,070 | $88.84 | $894,578 | 178,472 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:28 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 20,000 | $85.48 | $1,709,512 | 168,372 (Direct) | View |
| 2025-09-29 Sale | 2025-10-01 8:17 pm | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 27,588 | $85.05 | $2,346,256 | 201,010 (Direct) | View |
| 2025-09-29 Sale | 2025-10-01 8:14 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $83.07 | $332,288 | 174,363 (Direct) | View |
| 2025-09-15 Sale | 2025-09-17 4:31 pm | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $79.08 | $2,135,055 | 498,462 (Direct) | View |
| 2025-09-10 Sale | 2025-09-12 4:30 pm | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 3,725 | $78.83 | $293,642 | 123,146 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 4:30 pm | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $74.62 | $298,489 | 178,363 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 4:30 pm | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $75.42 | $2,036,325 | 525,462 (Direct) | View |
| 2025-08-07 Sale | 2025-08-08 4:30 pm | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,500 | $74.85 | $411,675 | 121,864 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-29 Exercise | 2026-02-02 4:30 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 5,500 | $0 | 166,946 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 5,500 | $27.85 | 166,946 (Direct) | View |
| 2026-01-21 Exercise | 2026-01-23 4:31 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 15,000 | $0 | 224,242 (Direct) | View |
| 2026-01-21 Exercise | 2026-01-23 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 15,000 | $27.85 | 224,242 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 5:27 pm | N/A 2036-01-07 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 17,500 | $0 | 100,888 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 5:26 pm | N/A 2036-01-07 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 17,500 | $0 | 75,617 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 5:26 pm | N/A 2036-01-07 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 17,500 | $0 | 77,134 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 5:26 pm | N/A 2036-01-07 | Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer | 17,500 | $0 | 90,130 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 5:25 pm | N/A 2036-01-07 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 17,500 | $0 | 116,733 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-07 5:25 pm | N/A 2036-01-07 | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 46,250 | $0 | 371,129 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-05 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 10,000 | $18.93 | 110,086 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-05 4:30 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 10,000 | $0 | 110,086 (Direct) | View |
| 2025-12-30 Exercise | 2026-01-02 4:20 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $0 | 162,363 (Direct) | View |
| 2025-12-30 Exercise | 2026-01-02 4:20 pm | N/A N/A | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $27.85 | 162,363 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,085 | $1.08 | 71,048 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 4:31 pm | N/A 2031-02-16 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,085 | $0 | 71,048 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 34,500 | $1.08 | 250,806 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 4:30 pm | N/A 2031-02-16 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 34,500 | $0 | 250,806 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 4:30 pm | N/A 2030-05-25 | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 57,000 | $0 | 815,004 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 57,000 | $0.65 | 815,004 (Direct) | View |
| 2025-12-10 Option Award | 2025-12-11 4:31 pm | N/A 2035-12-10 | Nuvalent Inc. | NUVL | Squarer Ron Director | 7,255 | $0 | 7,255 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-02 4:30 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $0 | 166,363 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-02 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $27.85 | 166,363 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:14 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 13,854 | $72.35 | 158,856 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:14 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 20,729 | $0 | 158,856 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:14 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 6,875 | $6.89 | 158,856 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:13 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 24,200 | $0 | 143,694 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:13 pm | N/A N/A | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 24,200 | $6.89 | 143,694 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-31 4:31 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $0 | 170,363 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-31 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $27.85 | 170,363 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-31 4:30 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 21,800 | $0 | 167,894 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-31 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 21,800 | $6.89 | 167,894 (Direct) | View |
| 2025-10-20 Exercise | 2025-10-22 4:32 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 5,000 | $0 | 189,694 (Direct) | View |
| 2025-10-20 Exercise | 2025-10-22 4:32 pm | N/A N/A | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 5,000 | $6.89 | 189,694 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-17 4:32 pm | N/A N/A | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $18.93 | 471,462 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-17 4:32 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $0 | 471,462 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:32 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 28,000 | $0 | 352,678 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:32 pm | N/A N/A | Nuvalent Inc. | NUVL | Miller Deborah Ann Chief Legal Officer | 28,000 | $6.89 | 352,678 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 3,668 | $18.93 | 113,746 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 3,042 | $72.35 | 113,746 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:31 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 14,205 | $0 | 113,746 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 7,495 | $27.85 | 113,746 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 1,683 | $18.93 | 90,713 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 4:31 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 1,683 | $0 | 90,713 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 33,125 | $18.93 | 179,034 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 40,000 | $0 | 179,034 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 6,875 | $6.89 | 179,034 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 2,400 | $18.93 | 178,472 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 1,800 | $72.35 | 178,472 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 10,070 | $0 | 178,472 (Direct) | View |
| 2025-10-14 Exercise | 2025-10-15 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 825 | $29.33 | 178,472 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,045 | $27.85 | 178,472 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:28 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 3,213 | $18.93 | 168,372 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:28 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 20,000 | $0 | 168,372 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:28 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 16,787 | $6.89 | 168,372 (Direct) | View |
| 2025-09-29 Exercise | 2025-10-01 8:17 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 27,588 | $0 | 201,010 (Direct) | View |
| 2025-09-29 Exercise | 2025-10-01 8:17 pm | N/A N/A | Nuvalent Inc. | NUVL | Balcom Alexandra Chief Financial Officer | 27,588 | $6.89 | 201,010 (Direct) | View |
| 2025-09-29 Exercise | 2025-10-01 8:14 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $0 | 174,363 (Direct) | View |
| 2025-09-29 Exercise | 2025-10-01 8:14 pm | N/A N/A | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $27.85 | 174,363 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-17 4:31 pm | N/A N/A | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $18.93 | 498,462 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-17 4:31 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $0 | 498,462 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 731 | $18.93 | 123,146 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:30 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 3,725 | $0 | 123,146 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 2,117 | $29.33 | 123,146 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 877 | $27.85 | 123,146 (Direct) | View |
| 2025-08-29 Exercise | 2025-09-03 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 3,000 | $1.08 | 71,048 (Direct) | View |
| 2025-08-29 Exercise | 2025-09-03 4:30 pm | N/A 2030-12-15 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,007 | $0 | 71,048 (Direct) | View |
| 2025-08-29 Exercise | 2025-09-03 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 2,007 | $0.87 | 71,048 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 4:30 pm | N/A 2033-01-06 | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $0 | 178,363 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Noci Darlene Chief Development Officer | 4,000 | $27.85 | 178,363 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $18.93 | 525,462 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 4:30 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Porter James Richard President and CEO | 27,000 | $0 | 525,462 (Direct) | View |
| 2025-08-07 Exercise | 2025-08-08 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 731 | $18.93 | 121,864 (Direct) | View |
| 2025-08-07 Exercise | 2025-08-08 4:30 pm | N/A 2032-01-04 | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 5,500 | $0 | 121,864 (Direct) | View |
| 2025-08-07 Exercise | 2025-08-08 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 3,892 | $29.33 | 121,864 (Direct) | View |
| 2025-08-07 Exercise | 2025-08-08 4:30 pm | N/A N/A | Nuvalent Inc. | NUVL | Pelish Henry E. Chief Scientific Officer | 877 | $27.85 | 121,864 (Direct) | View |